Table 1.
Demographics of participants.
| Variable | Range | |
|---|---|---|
| Number of participants | 21 | |
| Age, years (M ± SD) | 59.33 ± 8.67 | 41.00–71.00 |
| Body mass index, kg/m2 (median, IQR) | 25.20 (3.40) | 21.50–35.90 |
| Sex, number of men (%) | 15 (71.42) | |
| Multiple sclerosis type, number of RRMS (%) | 11 (52.38) | |
| Number of PPMS (%) | 9 (42.86) | |
| Number of SPMS (%) | 1 (4.76) | |
| Disease duration, year (M ± SD) | 14.57 ± 11.84 | 1–38.00 |
| Patient determined disease step (M ± SD) | 3.10 ± 1.26 | 1–6 |
| Health-related quality of life a (M ± SD) | 42.66 ± 8.13 | 31.17–57.07 |
| Engagement in pacing b (M ± SD) | 3.25 ± .74 | 1.60–4.60 |
| Perceived risk of overactivty b (M ± SD) | 3.38 ± 1.02 | 1.00–5.00 |
| Fatigue severity c (M ± SD) | 4.75 ± 1.62 | 1.00–7.00 |
| Physical activity counts d (M ± SD) | 257.97 ± 131.58 | 71.86–636.33 |
| Physical activity variability d (M ± SD) | 3.96 ± .72 | 2.87–5.93 |
M: mean; PPMS: primary progressive multiple sclerosis; SPMS: secondary progressive multiple sclerosis; RRMS: relapsing remitting multiple sclerosis; SD: standard deviation; IQR: interquartile range.
a
RAND-12 Health Survey.
b
Activity Pacing and Risk of Overactivity Questionnaire.
c
Fatigue Severity Scale.
d
ActiGraph accelerometer.